skip to Main Content

Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars?

The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars.
Go to Source
Author: Tatum Anderson

Back To Top